Beijing Bohui Innovation Biotechnology Group Co., Ltd. reported earnings results for the nine months ended September 30, 2023. For the nine months, the company reported sales was CNY 806.1 million compared to CNY 597.41 million a year ago. Revenue was CNY 806.1 million compared to CNY 597.41 million a year ago.

Net income was CNY 14.14 million compared to net loss of CNY 39.32 million a year ago. Basic earnings per share from continuing operations was CNY 0.0173 compared to basic loss per share from continuing operations of CNY 0.0481 a year ago. Diluted earnings per share from continuing operations was CNY 0.0173 compared to diluted loss per share from continuing operations of CNY 0.0481 a year ago.